Market Cap 990.56M
Revenue (ttm) 49.80M
Net Income (ttm) -50.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -101.08%
Debt to Equity Ratio 0.24
Volume 2,117,500
Avg Vol 2,715,694
Day's Range N/A - N/A
Shares Out 444.20M
Stochastic %K 70%
Beta 0.97
Analysts Sell
Price Target $3.52

Company Profile

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospit...

Industry: Biotechnology
Sector: Healthcare
Phone: 281 863 3000
Fax: 281 863 8088
Address:
2445 Technology Forest Boulevard, 11th Floor, The Woodlands, United States
Pit1908
Pit1908 May. 17 at 8:20 PM
$OCGN $LXRX One day, your story of resilience will be the light that guides someone else through the storm. 🙇🏻‍♂️ Every challenge you overcome today becomes a testimony of hope for those who will need it tomorrow! Patience is the key to success!🌈🧬💯 @SIRWINSALOT @TheUrbanFarmer
4 · Reply
Salishseas
Salishseas May. 17 at 6:49 PM
$LXRX @Pit1908 LOL!!! How many company tattoos are there on your body?
1 · Reply
Pit1908
Pit1908 May. 17 at 1:27 PM
$LXRX "Doing something that has an impact, that is lasting, that has the potential to change the future is an incredible opportunity and at the same time an unimaginable challenge." 🌍🌏🌎 It is as if Stefano had anticipated history, writing on his body the victorious ending of a challenge that many considered impossible.
0 · Reply
UofMAlum
UofMAlum May. 16 at 3:53 AM
0 · Reply
atreus57
atreus57 May. 16 at 3:51 AM
$LXRX this is almost like pattern repetition, expecting huge growth very soon, even the parameters match lol...
0 · Reply
GenericPoster
GenericPoster May. 15 at 9:30 PM
$LXRX Well, we are 45 days into 2Q 2026 so the various 13F’s are supposed to be filed even as it seems there are many older reports. I only see 7 filings for 1Q 2026 so may need to check other sources like NASDAQ for more complete filings; including those from large holders Invus and Artal who may be included in the Siren filing. Here is a summary and then the latest filings from: https://www.marketbeat.com/stocks/NASDAQ/LXRX/institutional-ownership/
2 · Reply
Hit1000X
Hit1000X May. 15 at 8:54 PM
$LXRX nothing burger for investors
0 · Reply
Beebomb
Beebomb May. 15 at 8:48 PM
$LXRX Despite a couple of days of retreat, I feel more confident than I have in years. Ekton's comments tell us the gun is loaded and the trigger figures to be pulled sooner rather than later. It makes no sense for a CEO of any public company to speak boldly without hard facts to back up his comments. The principals in this enterprise are serious people with serious abilities to make the cash register ring. Over the years I have consistently counseled patience. The good news: IMO, not much more is required before happy days.
1 · Reply
Pit1908
Pit1908 May. 15 at 8:42 PM
$LXRX 🌈🧬💪🏻 THE FIRST IN THE WORLD! This is REAL, not AI...
1 · Reply
Salishseas
Salishseas May. 15 at 8:21 PM
$LXRX LOL...someone just bought 768 shares at 2.32 after closing...🤪
1 · Reply
Latest News on LXRX
Lexicon price target raised to $3.10 from $2.30 at Citi

2026-05-11T11:01:50.000Z - 6 days ago

Lexicon price target raised to $3.10 from $2.30 at Citi


Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 10 days ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2026


Lexicon, Novo Nordisk announce initiation of LX9851 study

2026-03-23T11:46:37.000Z - 7 weeks ago

Lexicon, Novo Nordisk announce initiation of LX9851 study

NVO


Lexicon price target raised to $2.30 from $2.10 at Citi

2026-03-10T10:53:36.000Z - 2 months ago

Lexicon price target raised to $2.30 from $2.10 at Citi


Lexicon price target raised to $6 from $4 at H.C. Wainwright

2026-03-05T16:06:30.000Z - 2 months ago

Lexicon price target raised to $6 from $4 at H.C. Wainwright


Lexicon Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 2 months ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q4 2025


Lexicon reports Q4 EPS (4c), consensus (7c)

2026-03-05T12:08:49.000Z - 2 months ago

Lexicon reports Q4 EPS (4c), consensus (7c)


Lexicon announces common stock offering, no amount given

2026-01-29T21:36:16.000Z - 3 months ago

Lexicon announces common stock offering, no amount given


Lexicon Announces Proposed Public Offering of Common Stock

Jan 29, 2026, 4:31 PM EST - 3 months ago

Lexicon Announces Proposed Public Offering of Common Stock


Lexicon price target raised to $2.10 from $1.90 at Citi

2026-01-14T10:45:10.000Z - 4 months ago

Lexicon price target raised to $2.10 from $1.90 at Citi


Lexicon sees cash runway into 2027

2026-01-12T12:55:44.000Z - 4 months ago

Lexicon sees cash runway into 2027


Lexicon publishes White Paper on treatments for chronic pain

2026-01-09T13:40:14.000Z - 4 months ago

Lexicon publishes White Paper on treatments for chronic pain


Lexicon announces publication of preclinical data on ACSL5

2025-12-10T13:40:17.000Z - 5 months ago

Lexicon announces publication of preclinical data on ACSL5

NVO


Lexicon Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 6 months ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q3 2025


Lexicon reports Q3 EPS (4c), consensus (7c)

2025-11-06T12:41:13.000Z - 6 months ago

Lexicon reports Q3 EPS (4c), consensus (7c)


Lexicon Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 10 months ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q2 2025


Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Lexicon Pharmaceuticals Earnings Call Transcript: Q1 2025


Pit1908
Pit1908 May. 17 at 8:20 PM
$OCGN $LXRX One day, your story of resilience will be the light that guides someone else through the storm. 🙇🏻‍♂️ Every challenge you overcome today becomes a testimony of hope for those who will need it tomorrow! Patience is the key to success!🌈🧬💯 @SIRWINSALOT @TheUrbanFarmer
4 · Reply
Salishseas
Salishseas May. 17 at 6:49 PM
$LXRX @Pit1908 LOL!!! How many company tattoos are there on your body?
1 · Reply
Pit1908
Pit1908 May. 17 at 1:27 PM
$LXRX "Doing something that has an impact, that is lasting, that has the potential to change the future is an incredible opportunity and at the same time an unimaginable challenge." 🌍🌏🌎 It is as if Stefano had anticipated history, writing on his body the victorious ending of a challenge that many considered impossible.
0 · Reply
UofMAlum
UofMAlum May. 16 at 3:53 AM
0 · Reply
atreus57
atreus57 May. 16 at 3:51 AM
$LXRX this is almost like pattern repetition, expecting huge growth very soon, even the parameters match lol...
0 · Reply
GenericPoster
GenericPoster May. 15 at 9:30 PM
$LXRX Well, we are 45 days into 2Q 2026 so the various 13F’s are supposed to be filed even as it seems there are many older reports. I only see 7 filings for 1Q 2026 so may need to check other sources like NASDAQ for more complete filings; including those from large holders Invus and Artal who may be included in the Siren filing. Here is a summary and then the latest filings from: https://www.marketbeat.com/stocks/NASDAQ/LXRX/institutional-ownership/
2 · Reply
Hit1000X
Hit1000X May. 15 at 8:54 PM
$LXRX nothing burger for investors
0 · Reply
Beebomb
Beebomb May. 15 at 8:48 PM
$LXRX Despite a couple of days of retreat, I feel more confident than I have in years. Ekton's comments tell us the gun is loaded and the trigger figures to be pulled sooner rather than later. It makes no sense for a CEO of any public company to speak boldly without hard facts to back up his comments. The principals in this enterprise are serious people with serious abilities to make the cash register ring. Over the years I have consistently counseled patience. The good news: IMO, not much more is required before happy days.
1 · Reply
Pit1908
Pit1908 May. 15 at 8:42 PM
$LXRX 🌈🧬💪🏻 THE FIRST IN THE WORLD! This is REAL, not AI...
1 · Reply
Salishseas
Salishseas May. 15 at 8:21 PM
$LXRX LOL...someone just bought 768 shares at 2.32 after closing...🤪
1 · Reply
Iman133
Iman133 May. 15 at 7:35 PM
1 · Reply
don23jon18
don23jon18 May. 15 at 7:22 PM
0 · Reply
alcat1973
alcat1973 May. 15 at 7:20 PM
$LXRX Be great to see this close around 2.30 this afternoon. Have to be pleased with the share price since earnings. I know that I am. We have a stronger base after much profit taking so all we can do is we wait for those press releases.
0 · Reply
macrossluvsrobotech
macrossluvsrobotech May. 15 at 3:35 PM
$LXRX Smells like MA/Buyout courtship to me.
2 · Reply
Afrom74
Afrom74 May. 15 at 3:32 PM
$LXRX Thanks @Iman133
0 · Reply
Anon_ymous1
Anon_ymous1 May. 15 at 3:30 PM
$LXRX Thank you for keeping us updated @Iman133 This could very well be our time lads, all the catalysts are getting closer and closer.
0 · Reply
Iman133
Iman133 May. 15 at 3:22 PM
0 · Reply
Iman133
Iman133 May. 15 at 2:05 PM
0 · Reply
Iman133
Iman133 May. 15 at 1:34 PM
$LXRX Shorts are playing russian roulette every day. Sooner or later …
0 · Reply
TheMotleyMonk
TheMotleyMonk May. 15 at 1:32 PM
$LXRX https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-lxrx/lexicon-pharmaceuticals
0 · Reply
atreus57
atreus57 May. 15 at 12:46 PM
$LXRX I suggest you make a good statistical analysis of how often technical analysis is right and then decide for yourself whether to follow it or not... I did it and I never really used it after that...
0 · Reply
KurwaMac
KurwaMac May. 15 at 12:45 PM
$LXRX after options expire, are we ramping up towards 5/19 conference? Extons credibility is on the line this spring. “ We've taken steps, firstly, to strengthen our financial foundation over the last few months. And second, we've executed incredibly well. And as a result, we have many significant milestones just weeks away.” “So by next quarter, even in just the next few weeks, we believe we'll be able to share a number of positive developments, and we thank you for your continued attention and support.” -Exton 5/7
1 · Reply